EBIOPARTICLE Trademark

Trademark Overview


On Thursday, February 27, 2020, a trademark application was filed for EBIOPARTICLE with the United States Patent and Trademark Office. The USPTO has given the EBIOPARTICLE trademark a serial number of 88813315. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, March 9, 2023. This trademark is owned by Angany Inc.. The EBIOPARTICLE trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

(Based on 44(d) Priority Application) (Based on Intent to Use) Protein arrays for medical diagnosis purposes; proteins arrays for therapeutic use for treating cancer, allergies, autoimmune disease, infection disease, and inflammatory disease; biopharmaceuticals for treatment of cancer, allergies, autoimmune disease, infection disease; pharmaceutical preparations for use in the treatment of allergy, cancer, infectious diseases and immune diseases; pharmacological preparations able to effect immunotherapy with specific attributes of potency and safety

(Based on 44(d) Priority Application) (Based on Intent to Use) Chemicals for use in the manufacture of pharmaceuticals; proteins for immunoassay for detection, for diagnostic purposes, for therapeutic purposes and for treatment of cancer, allergies, autoimmune disease, infection diseases; all of the foregoing expressly excluding biologically-derived particles that can be fluorescently-labeled for scientific research purposes

(Based on 44(d) Priority Application) (Based on Intent to Use) Development of pharmaceutical preparations and medicines; drug discovery services; software as a service (SAAS) services featuring artificial intelligence software for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in the field of providing pharmaceutical products in order to create as many therapeutic different therapeutic agents deemed in the pharmaceutical industry and nanoparticles; platform as a service (PAAS) services featuring artificial intelligence software platforms for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining for use in the field of pharmacological and pharmaceutical products in order to create as many therapeutic different therapeutic agents deemed in the pharmaceutical industry and nanoparticles; platform as a service (PAAS) services featuring computer software platforms fo...
ebioparticle

General Information


Serial Number88813315
Word MarkEBIOPARTICLE
Filing DateThursday, February 27, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, March 9, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Services(Based on 44(d) Priority Application) (Based on Intent to Use) Protein arrays for medical diagnosis purposes; proteins arrays for therapeutic use for treating cancer, allergies, autoimmune disease, infection disease, and inflammatory disease; biopharmaceuticals for treatment of cancer, allergies, autoimmune disease, infection disease; pharmaceutical preparations for use in the treatment of allergy, cancer, infectious diseases and immune diseases; pharmacological preparations able to effect immunotherapy with specific attributes of potency and safety
Pseudo MarkE BIO PARTICLE
Goods and Services(Based on 44(d) Priority Application) (Based on Intent to Use) Chemicals for use in the manufacture of pharmaceuticals; proteins for immunoassay for detection, for diagnostic purposes, for therapeutic purposes and for treatment of cancer, allergies, autoimmune disease, infection diseases; all of the foregoing expressly excluding biologically-derived particles that can be fluorescently-labeled for scientific research purposes
Goods and Services(Based on 44(d) Priority Application) (Based on Intent to Use) Development of pharmaceutical preparations and medicines; drug discovery services; software as a service (SAAS) services featuring artificial intelligence software for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in the field of providing pharmaceutical products in order to create as many therapeutic different therapeutic agents deemed in the pharmaceutical industry and nanoparticles; platform as a service (PAAS) services featuring artificial intelligence software platforms for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining for use in the field of pharmacological and pharmaceutical products in order to create as many therapeutic different therapeutic agents deemed in the pharmaceutical industry and nanoparticles; platform as a service (PAAS) services featuring computer software platforms for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining for use in the field of pharmacological and pharmaceutical applications that is an immunomodulatory vector on which biologic targets determine the pertinence and use of these pharmacological agents

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, March 5, 2020
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 5, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 5, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAngany Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressQuebec (Quebec) G1R1R2
CA

Trademark Events


Event DateEvent Description
Thursday, March 9, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, March 9, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, March 9, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, January 17, 2023ASSIGNED TO EXAMINER
Thursday, August 25, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, August 25, 2022INQUIRY TO SUSPENSION E-MAILED
Thursday, August 25, 2022SUSPENSION INQUIRY WRITTEN
Thursday, August 25, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, February 24, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, February 24, 2022LETTER OF SUSPENSION E-MAILED
Thursday, February 24, 2022SUSPENSION LETTER WRITTEN
Thursday, February 3, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 3, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 26, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, September 22, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, September 22, 2021INQUIRY TO SUSPENSION E-MAILED
Wednesday, September 22, 2021SUSPENSION INQUIRY WRITTEN
Saturday, March 20, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, March 20, 2021LETTER OF SUSPENSION E-MAILED
Saturday, March 20, 2021SUSPENSION LETTER WRITTEN
Monday, February 22, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 22, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 22, 2021ASSIGNED TO LIE
Wednesday, November 18, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 18, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 18, 2020NON-FINAL ACTION E-MAILED
Monday, May 18, 2020NON-FINAL ACTION WRITTEN
Monday, May 18, 2020ASSIGNED TO EXAMINER
Thursday, March 5, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 5, 2020NEW APPLICATION ENTERED